These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Spectrum of immune-mediated necrotizing myopathies and their treatments. Pinal-Fernandez I; Mammen AL Curr Opin Rheumatol; 2016 Nov; 28(6):619-24. PubMed ID: 27607340 [TBL] [Abstract][Full Text] [Related]
8. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies. Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107 [TBL] [Abstract][Full Text] [Related]
9. Immune Mediated Necrotizing Myopathy: Where do we Stand? Mohammed AGA; Gcelu A; Moosajee F; Botha S; Kalla AA Curr Rheumatol Rev; 2019; 15(1):23-26. PubMed ID: 29623846 [TBL] [Abstract][Full Text] [Related]
10. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Pinal-Fernandez I; Casal-Dominguez M; Carrino JA; Lahouti AH; Basharat P; Albayda J; Paik JJ; Ahlawat S; Danoff SK; Lloyd TE; Mammen AL; Christopher-Stine L Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398 [TBL] [Abstract][Full Text] [Related]
11. Immune-mediated necrotising myopathy in asymptomatic patients with high creatine kinase. Soares IFZ; Comprido VF; Hsu BRRHS; Alves de Siqueira Carvalho A BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33033004 [TBL] [Abstract][Full Text] [Related]
12. Peculiar clinicopathological features of immune-mediated necrotizing myopathies. Allenbach Y; Benveniste O Curr Opin Rheumatol; 2018 Nov; 30(6):655-663. PubMed ID: 30239349 [TBL] [Abstract][Full Text] [Related]
13. Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments. Li C; Liu H; Yang L; Liu R; Yin G; Xie Q J Autoimmun; 2024 Sep; 148():103286. PubMed ID: 39033686 [TBL] [Abstract][Full Text] [Related]
14. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature. Cui BB; Tian YR; Ma XY; Yin G; Xie Q Front Immunol; 2021; 12():777502. PubMed ID: 34925350 [TBL] [Abstract][Full Text] [Related]
15. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy. Lia A; Annese T; Fornaro M; Giannini M; D'Abbicco D; Errede M; Lorusso L; Amati A; Tampoia M; Trojano M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Girolamo F Rheumatology (Oxford); 2022 Aug; 61(8):3448-3460. PubMed ID: 34864921 [TBL] [Abstract][Full Text] [Related]
17. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management. Basharat P; Christopher-Stine L Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574 [TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Arouche-Delaperche L; Allenbach Y; Amelin D; Preusse C; Mouly V; Mauhin W; Tchoupou GD; Drouot L; Boyer O; Stenzel W; Butler-Browne G; Benveniste O Ann Neurol; 2017 Apr; 81(4):538-548. PubMed ID: 28224701 [TBL] [Abstract][Full Text] [Related]
19. [Clinical and pathological characteristics of immune mediated necrotizing myopathy]. Yang HX; Tian XL; Jiang W; Li WL; Liu QY; Peng QL; Wang GC; Lu X Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):989-995. PubMed ID: 31848492 [TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review. Qiu R; Wang Z; Wei X; Sui H; Jiang Z; Yu XF Biomed Pharmacother; 2022 Dec; 156():113936. PubMed ID: 36411623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]